Nations Financial Group Inc, Amphastar Pharmaceuticals, Inc. Transaction History

Nations Financial Group Inc,

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$42.85 - $63.45 $17,097 - $25,316	399 Added 2.75%	14,923 $655,000
Q4 2023 Feb 09, 2024	BUY	$44.49 - $62.93 $177,159 - $250,587	3,982 Added 37.77%	14,524 $898,000
Q3 2023 Nov 14, 2023	BUY	$45.51 - $65.0 $63,213 - $90,285	1,389 Added 15.18%	10,542 $484,000
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $4,292 - $7,005	-120 Reduced 1.29%	9,153 $526,000
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $259,551 - $351,632	9,273 New	9,273 $347,000

282

35.2M

25.5K

24.8K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.62B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

Stay updated on Nations Financial Group Inc, with notifications on news.